SOMERVILLE, Mass., June 28, 2023 /PRNewswire/ -- Aitia, the leader in the application of Causal AI and Digital Twins to discover and develop new drugs, announced today that data from its Alzheimer's ...

LONDON, & BUDAPEST, Hungary--(BUSINESS WIRE)--Turbine, a computational biology company that deploys empirically validated in silico cell simulations to guide biopharma R&D, today announced that it has ...

Regulatory approval is only one marker of success for biotherapeutics. Biotherapeutics must also be commercially feasible. Too high a price tag can lead to limited availability to the targeted patient ...

Illustration of the setup for ‘in silico’ numerical experiments (MD simulations). The Cu tip, covered by graphene layer (red), slides over Cu substrate covered with another graphene layer (blue).

Simulations Plus is a specialized in silico software-and-services platform. They help with model-informed, non-animal drug development. SLP’s services help across discovery, development, and clinical ...